Abstract:Background and purpose: Differentiating high-grade gliomas (HGGs) from solitary brain metastases (SBMs) using conventional magnetic resonance imaging (MRI) remains challenging due to their similar imaging features. This study aimed to evaluate the diagnostic performance of advanced diffusion models, such as neurite orientation dispersion and density imaging (NODDI) and mean apparent propagator magnetic resonance imaging (MAP-MRI), incomparison to traditional techniques like diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI), and diffusion kurtosis imaging (DKI) for distinguishing HGGs from SBMs. Methods: In total, 17 patients with HGGs and 26 patients with SBMs were prospectively recruited based on the established inclusion and exclusion criteria. Structural MRI sequences and diffusion spectrum imaging (DSI) were utilized to assess quantitative parameter models, including NODDI, MAP-MRI, DWI, DTI, and DKI. Quantitative parameters were measured for both the tumor parenchymal area and the peritumoral edema area. The quantitative parameters of the two patient groups were compared using either the independent Student's t -test or the Mann–Whitney U test. The effectiveness of each model was evaluated using receiver operating characteristic (ROC) curves and calculating the area under the curve (AUC). Finally, the DeLong test was employed to compare the diagnostic performance of each model through pairwise comparisons of ROC curves. Results: Isotropic volume fraction (V iso ) based on NODDI; mean squared displacement (MSD) and the return to plane probabilities (RTPP) based on MAP-MRI; radial diffusivity (RD k ) and mean diffusivity (MD k ) based on DKI; and axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) based on DTI of the peritumoral edema tumor were significantly different between HGGs and SBMs ( p < 0.05). The optimal single discriminant parameters for each model are NODDI_V iso , MAP-MRI_MSD, DKI_MD k , and DTI_AD. Among these, the AUC of V iso (0.809) exceeds that of MSD (0.733), MD k (0.718), and AD (0.779). The combined model, which incorporates DTI_AD, DKI_RD, and NODDI_V iso , demonstrated superior diagnostic performance (0.897). Conclusions: Advanced diffusion MRI quantitative parameters derived from NODDI, such as V iso , have the potential to enhance the differentiation between HGGs and SBMs. The integrated utilization of these models is anticipated to enhance diagnostic accuracy and refine MRI protocols for brain tumor assessment.

Differentiation Between High‐Grade Glioma and Brain Metastasis Using Cerebral Perfusion‐Related Parameters (Cerebral Blood Volume and Cerebral Blood Flow): A Systematic Review and Meta‐Analysis of Perfusion‐weighted MRI Techniques

The Performance Of Mr Perfusion-Weighted Imaging For The Differentiation Of High-Grade Glioma From Primary Central Nervous System Lymphoma: A Systematic Review And Meta-Analysis

Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression

Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging

Combining Amide Proton Transfer-Weighted and Arterial Spin Labeling Imaging to Differentiate Solitary Brain Metastases from Glioblastomas

Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiation Between Recurrence and Pseudoprogression in High-Grade Glioma: A Meta-analysis

Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study

Diffusion MR Imaging for Preoperative Evaluation of Tumor Grade in Gliomas

Differentiation of grade II/III and grade IV glioma by combining “T1 contrast-enhanced brain perfusion imaging” and susceptibility-weighted quantitative imaging

Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma

Perfusion Imaging of Brain Gliomas Using Arterial Spin Labeling: Correlation with Histopathological Vascular Density in MRI-guided Biopsies

Multiparametric analysis from dynamic susceptibility contrast‐enhanced perfusion MRI to evaluate malignant brain tumors

Quantitative MR Perfusion for the Differentiation of Recurrence and Radionecrosis in Hypoperfusion and Hyperperfusion Brain Metastases After Gamma Knife Radiosurgery

Nimg-88. Evaluation Of Diffusion And Perfusion Mri Features For Differentiating Recurrent Brain Metastases And Radiation Necrosis

Differentiation between high-grade gliomas and solitary brain metastases based on multidiffusion MRI model quantitative analysis

Study on Diffusion and Perfusion MR Imaging for the Preoperative Evaluation of Tumor Grade in Gliomas

How to evaluate perfusion imaging in post-treatment glioma: a comparison of three different analysis methods

Multiparametric differentiation of intracranial central nervous system lymphoma and high-grade glioma using diffusion-, perfusion-, susceptibility-weighted magnetic resonance imaging, and spectroscopy

Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery

Correlative assessment of perfusion-related parameters of intravoxel incoherent motion with dynamic contrast ;enhancement in MR imaging of gliomas

Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging--An Institutional Experience